BioAge Labs: public offering milestone

BioAge announced IPO pricing, with Nasdaq trading expected September 26, 2024 and closing expected September 27, subject to conditions. Felicis lists the company in its historical portfolio; this event does not establish Felicis share sales, proceeds or disposal.